Lymph Flow Ingredients: The Six Herbal Extracts
Boswellia, curcumin, horse chestnut, gotu kola, quercetin phytosome and ginger — what each is documented for, what the research dosed, and why no figure from this label appears on this page.
Six names and nothing else
Lymph Flow contains six herbal ingredients.
They are boswellia serrata, curcumin, horse chestnut, gotu kola, quercetin phytosome and ginger extract. Single amounts are not listed, so this page explains what each one is known for.
What each one is documented for
Read down the right-hand column. For a product sold for drainage and circulation, this is a more coherent list than most.
1. Are you taking a blood thinner, or anything that affects clotting?
Yes — Then this is the question to take to a pharmacist before the first dose. Two of the six named ingredients — horse chestnut and ginger — carry documented anticoagulant and antiplatelet interactions, and no amount is declared for either. An interaction cannot be assessed against an amount that does not exist.
No — Then the interaction note on this page is background rather than urgent — but the amounts are still not declared.
2. Has your bottle arrived yet?
Yes — Then turn it around and read the panel on the back. That is the document this site could not get: it should list each of the six with an amount, plus servings per container. The research doses above are what to read it against.
No — Then note what to look for when it does: a Supplement Facts panel, six amounts, and a servings-per-container line.
3. Do you have any kidney or liver condition?
Yes — The horse chestnut monograph advises against use in renal or hepatic impairment. That advice is about a standardised, processed extract at a known dose; this label declares neither.
No — Then the label's general caution is the one that applies: talk to a doctor before use if you take medicine.
4. Can you judge it inside 60 days?
Yes — Then one bottle probably covers the window — though “probably” is doing work there, because a bottle is somewhere between 20 and 59 days depending on a figure nobody published.
No — Then look carefully at the bottle arithmetic above before buying six, because the window runs 60 days from purchase and the pack's own copy says most buyers wait four to eight weeks.
The doses the research used
The smallest daily amount each monograph reports, so that when your bottle arrives you have something to read its panel against.
- Boswellia Serrata Boswellia serrata900 mg a day
Clinical work used “300 to 400 mg of an extract (containing 60% boswellic acids) 3 times daily” for inflammatory conditions and for asthma — about 900 to 1,200 mg a day.
- Curcumin from Curcuma longa200 mg a day
Standardised curcuminoid doses in clinical trials run from “200 mg/day to 6 g/day”. The monograph also notes that curcumin “has limited medicinal use because of its low systemic bioavailability following oral dosing.”
- Horse Chestnut Aesculus hippocastanum500 mg a day
The venous-insufficiency dose is “250 to 312.5 mg (equivalent to aescin 100 mg) twice a day” of standardised seed extract, or aescin 20 to 40 mg three times daily. This is the ingredient on the list with the most direct claim to the product’s own subject.
- Gotu Kola Centella asiatica60 mg a day
“The recommended daily dose of titrated extracts of C. asiatica standardized for asiaticoside, asiatic acid, and madecassic acid is 60 to 120 mg.” Venous-hypertension trials used 60 mg two or three times a day.
- Quercetin Phytosome500 mg a day
“Most clinical studies use quercetin 500 to 1,000 mg per day in divided doses.” Phytosome names a lecithin-bound delivery form; the monograph notes absorption rises “in the presence of … lecithin” but gives no separate dose for it.
- Ginger Extract Zingiber officinale250 mg a day
“Ginger has been used in clinical trials in dosages of 170 mg to 1 g 3 to 4 times daily”; nausea trials ran 250 mg to 2 g a day.
Not one of these is a figure from this label, because this label supplies none. They are here so that when your bottle arrives with its panel on the back, you have something to read it against. Added together they come to 2,410 mg a day.
And what a serving could physically carry
- Water1.00 g/mL
- Vegetable glycerin1.26 g/mL
- Granulated sugar, loose0.85 g/mL
- This serving1.21 g/mL
A serving carrying the doses those studies used would have to be denser than pure vegetable glycerin — and denser in dissolved solids alone, before any of the liquid it is dissolved in. Alcohol-free herbal drops are not that. This says nothing about whether the product helps anyone; it says that whatever the missing panel turns out to contain, the amounts are far below the ones in the literature above, and no panel was needed to work that out.
Two interactions worth a pharmacist
Horse Chestnut
The monograph records that “all parts of plants in the Aesculus family are potentially toxic, especially the seeds (nuts)”, names esculin as “the most important toxic principle”, and reports that FDA classified it “an unsafe herb”. Clinical use is of standardised, processed seed extract. It also carries a warfarin interaction through its coumarin derivatives, and the monograph advises against use in renal or hepatic impairment.
Ginger
“Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of anticoagulants. Bleeding may occur.” The monograph lists warfarin, antiplatelet agents, NSAIDs, salicylates and thrombolytics.
Two of the six carry documented bleeding-related interactions, and no amount is declared for either of them. That is the combination worth taking to a pharmacist rather than working out alone, and it is the strongest practical reason on this page to want the panel.
What “Herbal Extracts” does not tell you
The front of the bottle says Herbal Extracts and stops there. An extract is a concentration, and the number that describes it — a ratio, a solvent, a standardised marker percentage — is what separates a clinical preparation from a flavouring.
- No ratio. A 10:1 extract and a 1:1 extract at the same milligram weight are different products.
- No solvent. The bottle says ALCOHOL FREE. Most tinctures are alcohol extractions; an alcohol-free one is usually glycerin or water based, and what a solvent pulls out of a plant depends on the solvent.
- No standardisation. This matters most for horse chestnut, where the monograph's clinical use is of a standardised, processed seed extract, and for boswellia, where the studied material is described by its boswellic acid content.
Sources for this page
- Frankincense, Indian (Boswellia serrata) — clinical monographDrugs.com natural products database“300 to 400 mg of a B. serrata extract (containing 60% boswellic acids) 3 times daily” for inflammatory conditions; 350 to 400 mg three times daily in ulcerative colitis.
- Turmeric — clinical monographDrugs.com natural products databaseStandardised curcuminoid doses of “200 mg/day to 6 g/day”; curcumin “has limited medicinal use because of its low systemic bioavailability following oral dosing.”
- Horse Chestnut — clinical monographDrugs.com natural products databaseStandardised seed extract “250 to 312.5 mg (equivalent to aescin 100 mg) twice a day” for chronic venous insufficiency; aescin 20 or 40 mg three times daily. All parts of the plant are potentially toxic, esculin being “the most important toxic principle”; FDA classified it “an unsafe herb”; warfarin interaction through coumarin derivatives.
- Gotu Kola — clinical monographDrugs.com natural products database“The recommended daily dose of titrated extracts of C. asiatica standardized for asiaticoside, asiatic acid, and madecassic acid is 60 to 120 mg”; venous-hypertension trials used 60 mg two or three times daily.
- Quercetin — clinical monographDrugs.com natural products database“Most clinical studies use quercetin 500 to 1,000 mg per day in divided doses”; absorption rises in the presence of fat, apple pectin, oligosaccharides and lecithin.
- Ginger — clinical monographDrugs.com natural products database“Ginger has been used in clinical trials in dosages of 170 mg to 1 g 3 to 4 times daily”; nausea trials 250 mg to 2 g a day. Anticoagulant and antiplatelet interactions are listed, with the note that “bleeding may occur.”
- Dietary Supplement Labeling Guide, Chapter IV: Nutrition LabelingU.S. Food and Drug AdministrationA Supplement Facts panel is required, with serving size, servings per container, and each dietary ingredient with its amount per serving; blend ingredients must be listed in descending order of predominance by weight. 21 CFR 101.36.